Your browser doesn't support javascript.
loading
In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI.
Schwenck, Johannes; Sonanini, Dominik; Seyfried, Dominik; Ehrlichmann, Walter; Kienzle, Gabriele; Reischl, Gerald; Krezer, Pascal; Wilson, Ian; Korn, Ron; Gonzalez-Menendez, Irene; Quintanilla-Martinez, Leticia; Seith, Ferdinand; Forschner, Andrea; Eigentler, Thomas; Zender, Lars; Röcken, Martin; Pichler, Bernd J; Flatz, Lukas; Kneilling, Manfred; la Fougere, Christian.
Afiliação
  • Schwenck J; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, Tübingen, Germany.
  • Sonanini D; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
  • Seyfried D; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, Tübingen, Germany.
  • Ehrlichmann W; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
  • Kienzle G; Department of Medical Oncology and Pneumology (Internal Medicine VIII), Eberhard Karls University, Tübingen, Germany.
  • Reischl G; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
  • Krezer P; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
  • Wilson I; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
  • Korn R; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
  • Gonzalez-Menendez I; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, Tübingen, Germany.
  • Quintanilla-Martinez L; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
  • Seith F; ImaginAb, Inc., Inglewood, California.
  • Forschner A; ImaginAb, Inc., Inglewood, California.
  • Eigentler T; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, Tübingen, Germany.
  • Zender L; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University, Tübingen, Germany.
  • Röcken M; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, Tübingen, Germany.
  • Pichler BJ; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University, Tübingen, Germany.
  • Flatz L; Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Tübingen, Germany.
  • Kneilling M; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.
  • la Fougere C; Department of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.
Theranostics ; 13(8): 2408-2423, 2023.
Article em En | MEDLINE | ID: mdl-37215571

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article